The title compound of sakuranetin, a main active flavanone component, was first isolated from Populus tomentosa Carr. and characterized by X-ray single-crystal diffraction analysis It crystallizes in the monoclinic la...The title compound of sakuranetin, a main active flavanone component, was first isolated from Populus tomentosa Carr. and characterized by X-ray single-crystal diffraction analysis It crystallizes in the monoclinic lattice, space group P21/c with a = 12.8531(12), b = 5.7141(3), c = 18.0355(12) A, β = 97.333(8)°, V = 1313.77(16) A^3, Z= 4, Mr = 286.27, C16H14O5,μ(MoKa) = 0.108 mm^-1, Dc = 1.447 g/cm^3, F(000) = 600, the final R = 0.0350 and wR = 0.0859 for 2571 independent reflections (Rint = 0.0246) which were used in all calculations. The molecular crystal structure of sakuranetin shows relative stereochemistry of 5,4′-dihydroxy-7-methoxyflavanone. Intermolecular hydrogen bonds together with the continuous π-π interactions construct the three-dimensional architecture of the title compound. The preliminary bioassay reveals that the title compound exhibits moderate anti-inflammatory activity in vitro against the nitric oxide release.展开更多
基金Supported by the Special Research Foundation of Beijing Municipal Bureau of Landscape and Forestry (No.Jingyuanlu 201005)the public welfareresearch special project in State Administration for Quality Supervision and Inspection and Quarantine (No. 201210209)
文摘The title compound of sakuranetin, a main active flavanone component, was first isolated from Populus tomentosa Carr. and characterized by X-ray single-crystal diffraction analysis It crystallizes in the monoclinic lattice, space group P21/c with a = 12.8531(12), b = 5.7141(3), c = 18.0355(12) A, β = 97.333(8)°, V = 1313.77(16) A^3, Z= 4, Mr = 286.27, C16H14O5,μ(MoKa) = 0.108 mm^-1, Dc = 1.447 g/cm^3, F(000) = 600, the final R = 0.0350 and wR = 0.0859 for 2571 independent reflections (Rint = 0.0246) which were used in all calculations. The molecular crystal structure of sakuranetin shows relative stereochemistry of 5,4′-dihydroxy-7-methoxyflavanone. Intermolecular hydrogen bonds together with the continuous π-π interactions construct the three-dimensional architecture of the title compound. The preliminary bioassay reveals that the title compound exhibits moderate anti-inflammatory activity in vitro against the nitric oxide release.